Hubei Jumpcan Pharmaceutical Co Ltd Financial Flexibility Index
Hubei Jumpcan Pharmaceutical Co Ltd financial flexibility index. Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of CN¥-212.62 Million (operating CF CN¥-243.75 Million minus capex CN¥31.12 Million) represents 0% of total liabilities (CN¥2.68 Billion). See 600566 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Financial flexibility index of Hubei Jumpcan Pharmaceutical Co Ltd from 2000 to 2025. Historical Financial Flexibility Index trend for Hubei Jumpcan Pharmaceutical Co Ltd across 26 annual periods. Check Hubei Jumpcan Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Hubei Jumpcan Pharmaceutical Co Ltd Financial Flexibility Index by Year (2000–2025)
Hubei Jumpcan Pharmaceutical Co Ltd financial flexibility index by year from 2000 to 2025. Year-by-year free cash flow to debt coverage for Hubei Jumpcan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Hubei Jumpcan Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥1.29 Billion | CN¥1.20 Billion | CN¥3.07 Billion | ▼ -33.0% |
| 2024 | 0.63x | CN¥2.35 Billion | CN¥2.18 Billion | CN¥3.73 Billion | ▼ -20.2% |
| 2023 | 0.79x | CN¥3.77 Billion | CN¥3.46 Billion | CN¥4.77 Billion | ▼ -0.1% |
| 2022 | 0.79x | CN¥2.86 Billion | CN¥2.62 Billion | CN¥3.63 Billion | ▲ +10.5% |
| 2021 | 0.71x | CN¥2.14 Billion | CN¥1.89 Billion | CN¥3.00 Billion | ▼ -11.1% |
| 2020 | 0.80x | CN¥2.21 Billion | CN¥1.78 Billion | CN¥2.75 Billion | ▼ -23.7% |
| 2019 | 1.05x | CN¥2.69 Billion | CN¥2.15 Billion | CN¥2.56 Billion | ▲ +3.6% |
| 2018 | 1.02x | CN¥2.38 Billion | CN¥1.71 Billion | CN¥2.34 Billion | ▲ +18.7% |
| 2017 | 0.86x | CN¥1.94 Billion | CN¥1.19 Billion | CN¥2.26 Billion | ▼ -10.0% |
| 2016 | 0.95x | CN¥1.24 Billion | CN¥913.10 Million | CN¥1.30 Billion | ▼ -20.3% |
| 2015 | 1.19x | CN¥1.04 Billion | CN¥645.48 Million | CN¥872.59 Million | ▲ +38.4% |
| 2014 | 0.86x | CN¥917.62 Million | CN¥616.11 Million | CN¥1.06 Billion | ▲ +33.4% |
| 2013 | 0.65x | CN¥557.27 Million | CN¥287.16 Million | CN¥862.04 Million | ▲ +352.8% |
| 2012 | 0.14x | CN¥71.68 Million | CN¥27.01 Million | CN¥502.07 Million | ▲ +1.6% |
| 2011 | 0.14x | CN¥61.15 Million | CN¥411.24K | CN¥435.00 Million | ▼ -62.2% |
| 2010 | 0.37x | CN¥127.63 Million | CN¥51.13 Million | CN¥342.89 Million | ▲ +894.3% |
| 2009 | 0.04x | CN¥12.11 Million | CN¥4.92 Million | CN¥323.37 Million | ▼ -61.4% |
| 2008 | 0.10x | CN¥31.39 Million | CN¥23.05 Million | CN¥323.43 Million | ▼ -33.9% |
| 2007 | 0.15x | CN¥44.55 Million | CN¥36.72 Million | CN¥303.49 Million | ▼ -21.3% |
| 2006 | 0.19x | CN¥56.07 Million | CN¥4.24 Million | CN¥300.69 Million | ▼ -61.9% |
| 2005 | 0.49x | CN¥123.18 Million | CN¥63.38 Million | CN¥251.96 Million | ▲ +302.5% |
| 2004 | 0.12x | CN¥27.21 Million | CN¥-37.74 Million | CN¥223.98 Million | ▼ -47.1% |
| 2003 | 0.23x | CN¥42.24 Million | CN¥2.24 Million | CN¥183.92 Million | ▼ -75.5% |
| 2002 | 0.94x | CN¥139.09 Million | CN¥22.00 Million | CN¥148.17 Million | ▲ +30.8% |
| 2001 | 0.72x | CN¥95.50 Million | CN¥7.43 Million | CN¥133.08 Million | ▲ +38.7% |
| 2000 | 0.52x | CN¥43.14 Million | CN¥23.73 Million | CN¥83.37 Million | — |